Heterogeneity in major depression and its melancholic and atypical specifiers: a secondary analysis of STAR*D

被引:19
作者
Lorenzo-Luaces, Lorenzo [1 ]
Buss, John F. [1 ]
Fried, Eiko, I [2 ]
机构
[1] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA
[2] Leiden Univ, Dept Psychol, NL-2333 AK Leiden, Netherlands
关键词
Depression; Classification; Melancholia; Atypical; SEQUENCED TREATMENT ALTERNATIVES; SYMPTOM PATTERNS; SUBTYPES; CRITERIA; EPIDEMIOLOGY; COMORBIDITY; RATIONALE; EXCLUSION; MODERATOR; VALIDITY;
D O I
10.1186/s12888-021-03444-3
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objectives The melancholic and atypical specifiers for a major depressive episode (MDE) are supposed to reduce heterogeneity in symptom presentation by requiring additional, specific features. Fried et al. (2020) recently showed that the melancholic specifier may increase the potential heterogeneity in presenting symptoms. In a large sample of outpatients with depression, our objective was to explore whether the melancholic and atypical specifiers reduced observed heterogeneity in symptoms. Methods We used baseline data from the Inventory of Depression Symptoms (IDS), which was available for 3,717 patients, from the Sequenced Alternatives to Relieve Depression (STAR*D) trial. A subsample met criteria for MDE on the IDS ("IDS-MDE"; N =2,496). For patients with IDS-MDE, we differentiated between those with melancholic, non-melancholic, non-melancholic, atypical, and non-atypical depression. We quantified the observed heterogeneity between groups by counting the number of unique symptom combinations pertaining to their given diagnostic group (e.g., counting the melancholic symptoms for melancholic and non-melancholic groups), as well as the profiles of DSM-MDE symptoms (i.e., ignoring the specifier symptoms). Results When considering the specifier and depressive symptoms, there was more observed heterogeneity within the melancholic and atypical subgroups than in the IDS-MDE sample (i.e., ignoring the specifier subgroups). The differences in number of profiles between the melancholic and non-melancholic groups were not statistically significant, irrespective of whether focusing on the specifier symptoms or only the DSM-MDE symptoms. The differences between the atypical and non-atypical subgroups were smaller than what would be expected by chance. We found no evidence that the specifier groups reduce heterogeneity, as can be quantified by unique symptom profiles. Most symptom profiles, even in the specifier subgroups, had five or fewer individuals. Conclusion We found no evidence that the atypical and melancholic specifiers create more symptomatically homogeneous groups. Indeed, the melancholic and atypical specifiers introduce heterogeneity by adding symptoms to the DSM diagnosis of MDE.
引用
收藏
页数:11
相关论文
共 48 条
[1]  
*AM PSYCH ASS, 1980, DIAGN STAT MENT DIS
[2]  
American Psychiatric Association, 2000, DIAGN STAT MENT DIS
[3]   Melancholia and atypical depression in the Zurich study:: epidemiology, clinical characteristics, course, comorbidity and personality [J].
Angst, J. ;
Gamma, A. ;
Benazzi, F. ;
Ajdacic, V. ;
Rossler, W. .
ACTA PSYCHIATRICA SCANDINAVICA, 2007, 115 :72-84
[4]  
[Anonymous], 2013, DIAGN STAT MAN MENT
[5]   Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial [J].
Arnow, Bruce A. ;
Blasey, Christine ;
Williams, Leanne M. ;
Palmer, Donna M. ;
Rekshan, William ;
Schatzberg, Alan F. ;
Etkin, Amit ;
Kulkarni, Jayashri ;
Luther, James F. ;
Rush, A. John .
AMERICAN JOURNAL OF PSYCHIATRY, 2015, 172 (08) :743-750
[6]   The predictive power of subgroups: An empirical approach to identify depressive symptom patterns that predict response to treatment [J].
Buehler, Joel ;
Seemueller, Florian ;
Laege, Damian .
JOURNAL OF AFFECTIVE DISORDERS, 2014, 163 :81-87
[7]   Reviewing the genetics of heterogeneity in depression: operationalizations, manifestations and etiologies [J].
Cai, Na ;
Choi, Karmel W. ;
Fried, Eiko, I .
HUMAN MOLECULAR GENETICS, 2020, 29 (R1) :R10-R18
[8]   Melancholic and atypical depression as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression [J].
Cuijpers, Pim ;
Weitz, Erica ;
Lamers, Femke ;
Penninx, Brenda W. ;
Twisk, Jos ;
DeRubeis, Robert J. ;
Dimidjian, Sona ;
Dunlop, Boadie W. ;
Jarrett, Robin B. ;
Segal, Zindel V. ;
Hollon, Steven D. .
DEPRESSION AND ANXIETY, 2017, 34 (03) :246-256
[9]   Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study [J].
Fava, M ;
Rush, AJ ;
Trivedi, MH ;
Nierenberg, AA ;
Thase, ME ;
Sackeim, HA ;
Quitkin, FM ;
Wisniewski, S ;
Lavori, PW ;
Rosenbaum, JF ;
Kupfer, DJ .
PSYCHIATRIC CLINICS OF NORTH AMERICA, 2003, 26 (02) :457-+
[10]  
Fried EI., 2014, PLOS ONE, V9, pe90311, DOI DOI 10.1371/JOURNAL.PONE.0090311